Detection of Extended-Spectrum β-Lactamase and Carbapenemase Activity in Gram-Negative Bacilli Using Liquid Chromatography – Tandem Mass Spectrometry

References

• Muntean D, Horhat FG, Badiţoiu L, et al. Multidrug-resistant gram-negative bacilli: a retrospective study of trends in a tertiary healthcare unit. Medicina. 2018;54(6):92 doi:10.3390/MEDICINA54060092
   Web of Science ®Google Scholar
• Muntean D, Licker M, Horhat F, et al. Extensively drug-resistant Acinetobacter baumannii and proteeae association in a Romanian intensive care unit: risk factors for acquisition. Infect Drug Resist. 2018;11:2187–2197. doi:10.2147/IDR.S17128830519056
   PubMed Web of Science ®Google Scholar
• Licker M, Sorescu T, Rus M, et al. Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients. Infect Drug Resist. 2018;11:743–749. doi:10.2147/IDR.S16106929849466
   PubMed Web of Science ®Google Scholar
• Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother. 2008;52(4):1413–1418. doi:10.1128/AAC.01103-0718227191
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang Y, Liu C, et al. Comparison of five commonly used automated susceptibility testing methods for accuracy in the China antimicrobial resistance surveillance system (CARSS) hospitals. Infect Drug Resist. 2018;11:1347–1358. doi:10.2147/IDR.S16679030214255
   PubMed Web of Science ®Google Scholar
• Bobenchik AM, Deak E, Hindler JA, Charlton CL, Humphries RM, Carroll KC. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. J Clin Microbiol. 2015;53(3):816–823. doi:10.1128/JCM.02697-1425540403
   PubMed Web of Science ®Google Scholar
• Ligozzi M, Bernini C, Bonora MG, De Fatima M, Zuliani J, Fontana R. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J Clin Microbiol. 2002;40(5):1681–1686. doi:10.1128/JCM.40.5.1681-1686.200211980942
   PubMed Web of Science ®Google Scholar
• Mittman SA, Huard RC, Della-Latta P, Whittier S. Comparison of BD phoenix to Vitek 2, MicroScan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol. 2009;47(11):3557–3561. doi:10.1128/JCM.01137-0919741088
   PubMed Web of Science ®Google Scholar
• Idelevich EA, Sparbier K, Kostrzewa M, Becker K. Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay. Clin Microbiol Infect. 2018;24(7):738–743. doi:10.1016/j.cmi.2017.10.01629079147
   PubMed Web of Science ®Google Scholar
• Camara JE, Hays FA. Discrimination between wild-type and ampicillin-resistant Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Bioanal Chem. 2007;389(5):1633–1638. doi:10.1007/s00216-007-1558-717849103
   PubMed Web of Science ®Google Scholar
• Carvalhaes CG, Cayô R, Visconde MF, et al. Detection of carbapenemase activity directly from blood culture vials using MALDI-TOF MS: a quick answer for the right decision. J Antimicrob Chemother. 2014;69(8):2132–2136. doi:10.1093/jac/dku09424722840
   PubMed Web of Science ®Google Scholar
• Hrabák J, Chudáčková E, Papagiannitsis CC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin Microbiol Infect. 2014;20(9):839–853. doi:10.1111/1469-0691.1267824813781
   PubMed Web of Science ®Google Scholar
• Dortet L, Tandé D, De Briel D, et al. MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NP. J Antimicrob Chemother. 2018;73(9):2352–2359. doi:10.1093/jac/dky20929897463
   PubMed Web of Science ®Google Scholar
• Hrabák J, Walková R, Študentová V, Chudáčková E, Bergerová T. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(9):3222–3227. doi:10.1128/JCM.00984-1121775535
   PubMed Web of Science ®Google Scholar
• Shah AJ, Vlad S, Xu Z, Mkrtchyan HV, Shah HN. Determination of antimicrobial resistance using tandem mass spectrometry In: Shah HN, Gharbia SE, editors. MALDI-TOF and Tandem MS for Clinical Microbiology. 1st ed John Wiley & Sons. 2017:399–418. doi:10.1002/9781118960226.ch15
   Google Scholar
• Tadros M, Goneau L, Romaschin A, Jarvis M, Matukas L, Gonzalez-Bello C. Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry. PLoS One. 2018;13(11):e0206842. doi:10.1371/journal.pone.020684230412608
   PubMed Web of Science ®Google Scholar
• Kulkarni MV, Zurita AN, Pyka JS, Murray TS, Hodsdon ME, Peaper DR. Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry. J Clin Microbiol. 2014;52(7):2500–2505. doi:10.1128/JCM.00547-1424789180
   PubMed Web of Science ®Google Scholar
• Peaper DR, Kulkarni MV, Tichy AN, Jarvis M, Murray TS, Hodsdon ME. Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC–MS/MS. Bioanalysis. 2013;5(2):147–157. doi:10.4155/bio.12.31023330558
   PubMed Web of Science ®Google Scholar
• Carricajo A, Verhoeven PO, Guezzou S, Fonsale N, Aubert G. Detection of carbapenemase-producing bacteria by using an ultra-performance liquid chromatography-tandem mass spectrometry method. Antimicrob Agents Chemother. 2014;58(2):1231–1234. doi:10.1128/AAC.01540-1324295978
   PubMed Web of Science ®Google Scholar
• Wayne P. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 29th Ed. CLSI Supplement M100. Clin Lab Stand Institute; 2019.
   Google Scholar
• Miriagou V, Tzelepi E, Kotsakis SD, Daikos GL, Bou Casals J, Tzouvelekis LS. Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers. Clin Microbiol Infect. 2013;19(9):E412–E415. doi:10.1111/1469-0691.1223823627340
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. 2019. doi:10.1007/978-3-662-48986-4_300416
   Google Scholar
• Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect. 2008;14(1):5–13. doi:10.1111/j.1469-0691.2007.01835.x
   Web of Science ®Google Scholar
• Depuydt P, Blot S. Antibiotic therapy for ventilator-associated pneumonia: de-escalation in the real world. Crit Care Med. 2007;35(2):632–633. doi:10.1097/01.CCM.0000254049.23884.D517251705
   PubMed Web of Science ®Google Scholar
• Colardyn F. Appropriate and timely empirical antimicrobial treatment of ICU infections - a role for carbapenems. Acta Clin Belg. 2005;60(2):51–62. doi:10.1179/acb.2005.01116082989
   PubMed Web of Science ®Google Scholar
• Truant AL, Yi‐Wei Tang KB. Manual of Commercial Methods in Clinical Microbiology: International Edition. Second John Wiley & Sons, Inc.; 2016. doi:10.1002/9781119021872
   Google Scholar
• Menegucci TC, Bastos MDS, Viana GF, et al. What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria? J Chemother. 2017;29(3):189–194. doi:10.1080/1120009X.2015.112040727077929
   PubMed Web of Science ®Google Scholar